Cardiovascular Risk and Diagnostics

Understanding Cardiovascular Risk Factors

Cardiovascular disease (CVD) remains the leading cause of mortality worldwide. Effective prevention hinges on recognizing which risk factors can be modified through lifestyle changes and which are non‑modifiable. This section explores the key determinants of coronary artery disease (CAD) and provides evidence‑based guidance for risk reduction.

Non‑modifiable vs. Modifiable Risk Factors

• Age: The risk of CAD rises sharply after 45 years in men and 55 years in women. This factor cannot be altered by lifestyle, but awareness allows clinicians to tailor screening and preventive strategies.
• Low physical activity: Sedentary behavior increases the likelihood of hypertension, dyslipidaemia, and obesity. Regular aerobic exercise (≥150 min/week) mitigates these risks.
• Unhealthy eating habits: Diets high in saturated fats, trans‑fatty acids, and refined sugars promote atherogenic lipid profiles. A Mediterranean‑style diet is protective.
• Smoking tobacco: Cigarette smoking accelerates endothelial damage and thrombosis. Smoking cessation is one of the most impactful interventions.

Among the options, age over 45 in men or 55 in women is the only factor that cannot be modified by lifestyle changes.

Blood Pressure Targets: What Do Current Guidelines Recommend?

Hypertension is a major modifiable risk factor for both stroke and coronary artery disease. Recent guidelines from the American College of Cardiology (ACC) and the European Society of Cardiology (ESC) converge on a clear target for optimal blood pressure.

Optimal Blood Pressure Range

• Systolic blood pressure (SBP): Less than 120 mmHg
• Diastolic blood pressure (DBP): Less than 80 mmHg

This “< 120/80 mmHg” goal is associated with the lowest risk of cardiovascular events. Values between 120‑129 mmHg systolic with a DBP < 80 mmHg are considered elevated, while 130‑139 mmHg/80‑89 mmHg define stage 1 hypertension.

Achieving these targets typically requires a combination of lifestyle modification (dietary sodium reduction, weight loss, exercise) and, when necessary, pharmacologic therapy.

Diagnostic Tools for Coronary Artery Disease

Accurate diagnosis of CAD relies on a spectrum of non‑invasive and invasive techniques. Understanding the purpose and capabilities of each modality is essential for appropriate patient management.

Direct Visualisation: Coronography

Coronography (also known as coronary angiography) involves the injection of contrast dye into the coronary arteries followed by X‑ray imaging. This invasive procedure provides a direct visualisation of arterial lumen, plaque burden, and stenosis severity.

• Indications: Acute coronary syndrome, unclear non‑invasive test results, pre‑revascularisation planning.
• Advantages: Gold‑standard for anatomical assessment, allows immediate therapeutic interventions (e.g., percutaneous coronary intervention).
• Limitations: Invasive, exposure to radiation and contrast agents.

Other modalities mentioned in the quiz—transthoracic echocardiography, lipidogram, and electrocardiogram—provide valuable information but do not directly visualise coronary arteries.

Acute Coronary Syndrome and Nitroglycerin Response

Nitroglycerin (NTG) is a cornerstone of symptomatic relief in acute coronary syndromes (ACS). Its vasodilatory effect reduces myocardial oxygen demand and alleviates chest pain.

Typical Clinical Response

In most patients with ACS, NTG produces a weak relief of chest pain. The relief is often partial because the underlying ischemia may be extensive, and the drug does not address plaque rupture directly.

• Rapid onset: Effects begin within 1–3 minutes after sublingual administration.
• Duration: Relief lasts 15–30 minutes, prompting repeat dosing if needed.
• Interpretation: Persistent severe pain despite NTG warrants urgent reperfusion therapy.

Understanding the expected response helps clinicians differentiate between typical angina relief and red‑flag scenarios requiring immediate intervention.

Non‑Pharmacological Management of Hypertension

Lifestyle modification is the first line of defense against hypertension. Several evidence‑based strategies can lower blood pressure by 5‑10 mmHg, reducing cardiovascular risk substantially.

Key Components

• Regular physical activity: At least 150 minutes of moderate‑intensity aerobic exercise per week.
• Smoking cessation: Eliminates a major vascular toxin and improves endothelial function.
• Weight reduction: A 5‑kg weight loss can lower SBP by ~5 mmHg.
• Dietary modifications: DASH diet, reduced sodium (

The statement that increasing salt intake is a component of non‑pharmacological hypertension management is incorrect; excessive sodium is a well‑documented contributor to elevated blood pressure.

Implementing these measures alongside patient education yields sustainable blood pressure control and improves overall cardiovascular health.

Summary and Clinical Take‑aways

By mastering the concepts covered in this course, healthcare professionals can:

• Identify non‑modifiable risk factors (e.g., age) and focus preventive efforts on modifiable ones.
• Target blood pressure below 120/80 mmHg to minimise cardiovascular events.
• Select appropriate diagnostic tools, recognising that coronography offers direct coronary artery visualisation.
• Interpret the typical, modest response to nitroglycerin in acute coronary syndrome.
• Apply evidence‑based, non‑pharmacological strategies—excluding harmful practices like increased salt intake—to manage hypertension.

Continual education and patient‑centred counseling remain pivotal in reducing the global burden of cardiovascular disease.